These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 31399111

  • 1. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J, Li H, Shi M, Zhu Y, Ma Y, Zhong Y, Xiong C, Chen H, Peng C.
    J Exp Clin Cancer Res; 2019 Aug 09; 38(1):348. PubMed ID: 31399111
    [Abstract] [Full Text] [Related]

  • 2. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H, Yan Z, Chen W, Wu Y, Han J, Guo H, Qiao J.
    Gynecol Oncol; 2017 Nov 09; 147(2):408-417. PubMed ID: 28851501
    [Abstract] [Full Text] [Related]

  • 3. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
    Fan J, Zhang Y, Mu J, He X, Shao B, Zhou D, Peng W, Tang J, Jiang Y, Ren G, Xiang T.
    Clin Epigenetics; 2018 Aug 03; 10(1):103. PubMed ID: 30075814
    [Abstract] [Full Text] [Related]

  • 4. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
    Guo H, Zhu H, Zhang J, Wan B, Shen Z.
    J Cell Biochem; 2019 Aug 03; 120(8):12559-12565. PubMed ID: 30825236
    [Abstract] [Full Text] [Related]

  • 5. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
    Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY, Yan M, Gu QL, Zhu ZG, Liu BY.
    Oncotarget; 2016 May 24; 7(21):31322-35. PubMed ID: 27121319
    [Abstract] [Full Text] [Related]

  • 6. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
    Zeng X, Zhang Y, Xu H, Zhang T, Xue Y, An R.
    Cell Physiol Biochem; 2018 May 24; 50(5):1815-1831. PubMed ID: 30396168
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ, Chen S, Gu JN, Zhu Y, Zhan Q, Cheng DF, Chen H, Deng XX, Shen BY, Peng CH.
    J Cell Biochem; 2018 Jan 24; 119(1):1027-1040. PubMed ID: 28685847
    [Abstract] [Full Text] [Related]

  • 8. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z, Zhang HS, Liu Y, Zhang ZG, Du GY, Li H, Yu XY, Huang YH.
    J Cell Physiol; 2018 Feb 24; 233(2):1359-1369. PubMed ID: 28513825
    [Abstract] [Full Text] [Related]

  • 9. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
    Li H, Jiang W, Liu XN, Yuan LY, Li TJ, Li S, Xu SS, Zhang WH, Gao HL, Han X, Wang WQ, Wu CT, Yu XJ, Xu HX, Liu L.
    Oncogene; 2020 Sep 24; 39(36):5825-5838. PubMed ID: 32753651
    [Abstract] [Full Text] [Related]

  • 10. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
    Neri F, Dettori D, Incarnato D, Krepelova A, Rapelli S, Maldotti M, Parlato C, Paliogiannis P, Oliviero S.
    Oncogene; 2015 Aug 06; 34(32):4168-76. PubMed ID: 25362856
    [Abstract] [Full Text] [Related]

  • 11. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
    Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, Wang X, Gu C, Wang Y, Ye L, Han L, Lin X, Chen J, Cai J, Li A, Liu S.
    J Exp Clin Cancer Res; 2019 Aug 01; 38(1):334. PubMed ID: 31370857
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M.
    BMC Cancer; 2013 Oct 25; 13():496. PubMed ID: 24156409
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA TINCR suppresses growth and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin signaling pathway in human pancreatic cancer PANC-1 cells: Insights from in vitro and in vivo studies.
    Wei Y, Zhu P.
    Acta Pharm; 2024 Mar 01; 74(1):131-147. PubMed ID: 38554384
    [Abstract] [Full Text] [Related]

  • 14. HOTAIR Knockdown Decreased the Activity Wnt/β-Catenin Signaling Pathway and Increased the mRNA Levels of Its Negative Regulators in Hela Cells.
    Salmerón-Bárcenas EG, Illades-Aguiar B, Del Moral-Hernández O, Ortega-Soto A, Hernández-Sotelo D.
    Cell Physiol Biochem; 2019 Mar 01; 53(6):948-960. PubMed ID: 31820855
    [Abstract] [Full Text] [Related]

  • 15. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W, Wang Z, Zhang S, Lu X, Wu J, Yu K, Ji A, Lu W, Wang Z, Wu J, Jiang C.
    Sci Rep; 2019 May 17; 9(1):7539. PubMed ID: 31101875
    [Abstract] [Full Text] [Related]

  • 16. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M, Han YM, Han Q, Rong XZ, Liu XF, Ln XY.
    J Cell Mol Med; 2021 Oct 17; 25(19):9411-9426. PubMed ID: 34453479
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/β-Catenin Pathway.
    Ji J, You Q, Zhang J, Wang Y, Cheng J, Huang X, Zhang Y.
    Anal Cell Pathol (Amst); 2021 Oct 17; 2021():8980711. PubMed ID: 34926132
    [Abstract] [Full Text] [Related]

  • 18. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
    Tao C, Luo J, Tang J, Zhou D, Feng S, Qiu Z, Putti TC, Xiang T, Tao Q, Li L, Ren G.
    Clin Epigenetics; 2020 Nov 17; 12(1):173. PubMed ID: 33203470
    [Abstract] [Full Text] [Related]

  • 19. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W, Wang Z, Zhang W, Qian K, Li H, Kong D, Li Y, Tang Y.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):613-27. PubMed ID: 25305448
    [Abstract] [Full Text] [Related]

  • 20. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G, Armbruster N, Bodenhöfer M, Haerle U, Behrens D, Buchholz M, Rothbauer U, Sipos B, Schmees C.
    Oncotarget; 2016 Nov 08; 7(45):73725-73738. PubMed ID: 27713160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.